Algol Pharma signed a distribution & marketing agreement with Tillotts Pharma

Algol Pharma Oy has signed an agreement with Tillotts Pharma AB the concerning distribution and marketing of ASACOL® products in the Baltic States. ASACOL® (active ingredient: mesalazine) is an anti-inflammatory drug used to treat inflammatory bowel disease (ulcerative colitis and mild-to-moderate Crohn’s disease). Tillotts Pharma (www.tillotts.com), part of the Zeria Group, is a fast-growing specialty pharma company with 200 employees in Switzerland and abroad. Tillotts is dedicated to the development, in/out-licensing and commercialization of innovative pharmaceutical products, medical devices and diagnostics, all in the field of gastroenterology.